HTG Molecular Diagnostics (HTGM) Tops Q2 EPS by 11c

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q2 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $1.49 million versus the consensus estimate of $2.35 million.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Integra Resources (ITRG) Tops Q2 EPS by 6c
• Adecoagro S.A. (AGRO) Misses Q2 EPS by 63c